Management Team

John K. Stroh joined Neomatrix as Chief Executive Officer and Director in November 2007. Mr. Stroh brings over 25 years of experience in operations, finance, investment banking and M&A, primarily in the medical technology field. Before joining Neomatrix, Mr. Stroh was with Organon BioSciences N.V where he led the financial integration efforts for their acquisition of Kadmus Pharmaceuticals. Inc. From January 2003 until the acquisition by Organon in May of 2007 John was the COO & CFO of Kadmus. From 2001 to 2003, he was the President and Managing Partner of Global Healthcare Advisors and acting CFO of Atairgin Technologies Inc an early stage Medical Technology Company focused on Ovarian & Breast Cancer diagnostics. From 1984 until joining Atairgin in 2001, Mr. Stroh worked as a Managing Director and Vice President for John Nuveen & Company, US Bancorp Piper Jaffrey, Smith Barney Shearson, Roth Capital Partners and Kidder Peabody & Co. During this period, he was instrumental in raising over $2 billion for client companies and consulted on over 100 mergers and strategic partnering transactions. Mr. Stroh began his career with Johnson & Johnson working in various sales, marketing and management positions. He is a frequent guest speaker on corporate finance and is on the board of directors of Kadmus Pharmaceuticals, Ltd. (the Canadian division of Kadmus Pharmaceuticals Inc.), a privately-held biopharmaceutical company, and Vesta Medical, LLC, a privately-held medical waste company. Mr. Stroh earned a bachelor degree in business from California State University, Long Beach, and attended the Graduate School of Management at Long Beach and UCLA.